Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 3/20 | 0.57 |
| ▸ | HTR2B | P41595 | 1/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.47 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 5/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | AHR | P35869 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | S100A4 | P26447 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29489601 | 1.00 | TP53 (0.57) | TP53HTR2BPDE4DCNR2TSHR | |
| SCHEMBL4445036 | 0.85 | CNR2 (0.46) | TP53HTR2BPDE4DCNR2TSHR | |
| SCHEMBL440944 | 0.83 | TP53 (0.61) | TP53HTR2BPDE4DTSHRALDH1A1 | |
| SCHEMBL29364307 | 0.83 | TP53 (0.61) | TP53HTR2BPDE4DTSHRALDH1A1 | |
| SCHEMBL4445059 | 0.82 | TP53 (0.48) | TP53HTR2BPDE4DCNR2TSHR | |
| SCHEMBL4459784 | 0.81 | TP53 (0.42) | TP53HTR2BPDE4DCNR2TSHR | |
| SCHEMBL4452962 | 0.81 | AHR (0.56) | TP53TSHRALDH1A1CYP3A4HSD17B10 | |
| SCHEMBL4450570 | 0.80 | TP53 (0.46) | TP53HTR2BPDE4DCNR2TSHR | |
| SCHEMBL4454535 | 0.80 | TP53 (0.52) | TP53HTR2BPDE4DCNR2TSHR | |
| SCHEMBL29618916 | 0.80 | TP53 (0.46) | TP53HTR2BPDE4DCNR2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250051430-A1 | NEUTRALIZATION OF ACYL-COA BINDING PROTEIN CONFERS AUTOPHAGY-DEPENDENT ORGAN PROTECTION | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-02-13 | — | — | US | claimed |
| EP-4475883-A1 | NEUTRALIZATION OF ACYL-COA BINDING PROTEIN CONFERS AUTOPHAGY-DEPENDENT ORGAN PROTECTION | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2024-12-18 | — | — | EP | claimed |
| WO-2023152637-A1 | NEUTRALIZATION OF ACYL-COA BINDING PROTEIN CONFERS AUTOPHAGY-DEPENDENT ORGAN PROTECTION | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-08-17 | — | — | WO | claimed |
| CN-111411051-B | Lactobacillus helveticus and application thereof | 江南大学 | 2022-04-22 | — | — | CN | claimed |
| CN-111073828-B | Bifidobacterium longum subspecies longum and application thereof | 江南大学 | 2022-04-15 | — | — | CN | claimed |
| EP-3881907-A1 | METHOD FOR DECHLORINATION OF ONE OR MORE AROMATIC ORGANOCHLORINE COMPOUND(S) CONTAINED IN AN OIL OR FORMING SAID OIL - ASSOCIATED ELECTRICAL/ELECTRONIC DEVICE AND INSTALLATION | Université de Lille (FR) | 2021-09-22 | — | — | EP | claimed |
| EP-3752148-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING TEIXOBACTIN AND A PEGYLATED PHOSPHOLIPID, AND THEIR USE IN TREATING BACTERIAL INFECTION | NOVOBIOTIC PHARMACEUTICALS LLC (US) | 2026-05-27 | — | — | EP | disclosed |
| US-12622925-B2 | Edible enterosorbents used to mitigate acute exposures to ingestible environmental toxins following outbreaks, natural disasters and emergencies | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2026-05-12 | — | — | US | disclosed |
| US-20260069588-A1 | VEPDEGESTRANT FOR USE IN TREATING CANCER | ARVINAS OPERATION INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-12545677-B2 | Compounds useful as factor XIa inhibitors | JANSSEN PHARMACEUTICA NV (BE) | 2026-02-10 | — | — | US | disclosed |
| US-20250303213-A1 | IN SITU TREATMENT SYSTEMS FOR REMEDIATION OF POLYCHLORINATED BIPHENYL CONTAMINATED BUILDING MATERIALS | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. | 2025-10-02 | — | — | US | disclosed |
| EP-4622951-A1 | SELECTIVE BETA2-ADRENOCEPTOR ANTAGONIST | Trio Medicines Limited (GB) | 2025-10-01 | — | — | EP | disclosed |
| EP-4185587-B1 | COMPOUNDS USEFUL AS FACTOR XIA INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2025-09-10 | — | — | EP | disclosed |
| US-20170114187-A9 | GELS | AORTECH INTERNATIONAL PLC (GB) | 2017-04-27 | — | — | US | disclosed |
| US-20140323676-A1 | GELS | AORTECH INTERNATIONAL PLC (GB) | 2014-10-30 | — | — | US | disclosed |
| US-8623986-B2 | Gels | Aertech International plc (GB) | 2014-01-07 | — | — | US | disclosed |
| US-20100029802-A1 | Gels | AORTECH INTERNATIONAL PLC (GB) | 2010-02-04 | — | — | US | disclosed |
| US-20090269857-A1 | Instruments for detecting low-molecular weight substance | FUJIKURA KASEI CO., LTD. (JP) | 2009-10-29 | — | — | US | disclosed |
| US-20050148097-A1 | Instruments for detecting low-molecular weight substance | ENBIOTEC LABORATORIES C., LTD. (JP) | 2005-07-07 | — | — | US | disclosed |
| EP-1489420-A1 | INSTRUMENTS FOR DETECTING LOW-MOLECULAR WEIGHT SUBSTANCE | Enbiotec Laboratories Co., Ltd. (JP) | 2004-12-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622925-B2 | Edible enterosorbents used to mitigate acute exposures to ingestible environmental toxins following outbreaks, natural disasters and emergencies | FABP2, LCT, DDT | TP53 380/4885HTR2B 1151/4885PDE4D 4073/4885 |
| US-12545677-B2 | Compounds useful as factor XIa inhibitors | F2, F11, F10 | TP53 4071/4885HTR2B 2642/4885PDE4D 3777/4885 |
| US-20260069588-A1 | VEPDEGESTRANT FOR USE IN TREATING CANCER | PSMC1, PSMC5, PSME3 | TP53 163/4885HTR2B 2991/4885PDE4D 2685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.